Journal silently fixes emergency care paper — after misleading press coverage

Last month, a colleague of emergency medicine doctor Daniel Waxman sent him some newly reported findings that took him by surprise. Waxman knew from the title of a press release about the recent paper — “Nearly Half of U.S. Medical Care Comes From Emergency Rooms” — that something was wrong.

Immediately I said, that’s not true. It’s just crazy.

Waxman quickly realized the mistake: The data were based only on care provided in hospitals — much of which, not surprisingly, originates from emergency departments (EDs). But the title of the paper, the abstract, and other places in the text do not specify that. What’s more,  the press release about the study says the findings relate to “all medical care.” The journal has since changed the paper, including the title, to make that distinction clear, but not provided any editorial notice indicating the text had been updated. Meanwhile, the press release and news stories about the original study continue to report the “surprising” original findings.

Continue reading Journal silently fixes emergency care paper — after misleading press coverage

Lawyers call libel suit against journal and critic “lawless” but “well written”

Mark Jacobson

A $10 million defamation suit filed by a Stanford University professor against a critic and a journal may be an assault on free speech, according to one lawyer, but at least it’s “well written.”

Kenneth White, a lawyer at Southern California firm Brown White & Osborn who frequently blogs about legal issues related to free speech at Popehat, told us:

It’s not incompetently drafted, but it’s clearly vexatious and intended to silence dissent about an alleged scientist’s peer-reviewed article.

Scientists have publicly bemoaned the suit’s existence, as reported by several outlets, including Mashable and Nature. Mark Jacobson, an engineering professor at Stanford, has alleged that he was defamed in a June article published in the Proceedings of the National Academy of Sciences (PNAS), which was critical of a 2015 paper co-authored by Jacobson in the same journal. In a complaint filed Sept. 29 in the Superior Court of the District of Columbia, Jacobson accused the journal’s publisher, the National Academy of Sciences, and the paper’s first author, Christopher Clack, an executive at a renewable energy analysis firm, of libel.

White told us that there are several pitfalls that could trip up the lawsuit, including a DC law that allows defendants an early opportunity to ask the court to dismiss cases muzzling free speech and recover attorneys’ fees. But another attorney said the complaint should at least clear the lowest hurdle in the way of getting to trial. Continue reading Lawyers call libel suit against journal and critic “lawless” but “well written”

Caught Our Notice: Dear peer reviewer, please read the methods section. Sincerely, everyone

Via Wikimedia

TitlePlasma contributes to the antimicrobial activity of whole blood against Mycobacterium tuberculosis

What Caught Our Attention: A big peer review (and perhaps academic mentorship) fail.  These researchers used the wrong anticoagulant for their blood samples, leading them to believe that certain blood components were fighting microbes. The authors counted the number of colonies to show how well or poorly Tuberculin mycobacteria were growing in cultures — but blood samples need anticoagulants to prevent clots before analysis, and they used an anticoagulant that actually prevented the microbes from colonizing. The authors (and reviewers) should have known this from  Continue reading Caught Our Notice: Dear peer reviewer, please read the methods section. Sincerely, everyone

Carlo Croce, facing misconduct allegations, accuses former colleague of misconduct

Carlo Croce

Carlo Croce, a cancer researcher who has faced numerous research misconduct allegations, recently accused a former lab member of misconduct. Although an institutional probe did not support that allegation, Croce’s efforts have led to a retraction.

In November 2015, Croce and another cancer researcher at Ohio State University (OSU), Ramiro Garzon, contacted PLOS ONE, alleging that the paper’s corresponding author, Stefan Costinean, published data without their knowledge or permission and without “accurately acknowledging their contributions to the research.” Although the PLOS ONE paper mentioned Croce’s and Garzon’s contributions in the acknowledgements section, the two were not included as co-authors. We have obtained a copy of the report describing OSU’s preliminary probe; it did not find evidence of misconduct, but recommended the paper be retracted for using data without permission. Although Costinean disagreed, the journal has since retracted the paper.

Croce has been on the other side of this process: Seven of his papers have been retracted for issues including manipulation and duplication. After a New York Times article, published in March, explored misconduct allegations against Croce, OSU said the university is “instituting an independent external review.” Croce is currently suing the New York Times, alleging that the newspaper defamed him in the story.

Continue reading Carlo Croce, facing misconduct allegations, accuses former colleague of misconduct

Caught Our Notice: A nearly unreadable paper criticizing 2017 Nobel pick

Via Wikimedia

Title: Nobel Prize Physiology 2017 (for their discoveries of molecular mechanisms controlling the circadian rhythm) is On Fiction as There Is No Molecular Mechanisms of Biological Clock Controlling the Circadian Rhythm. Circadian Rhythm Is Triggered and Controlled By Divine Mechanism (CCP – Time Mindness (TM) Real Biological Clock) in Life Sciences 

What Caught Our Attention: This isn’t a retraction — rather, it’s a puzzling paper that we couldn’t help flagging for readers. From the title, to the affiliation (Das Nursing Home, India University Of God), to the reference list with only 11 entries — eight of which are written by the author himself — this is a paper that got our notice.

Continue reading Caught Our Notice: A nearly unreadable paper criticizing 2017 Nobel pick

Caught Our Notice: Author of controversial retracted paper earns Swedish gov’t grant

Last week, a Swedish government funding agency announced 325 recipients of grants in Natural and Engineering Sciences. We don’t normally write about grant announcements, but we’re flagging this one because one recipient may be familiar to our readers.

It is Peter Eklöv of Uppsala University, a co-author of a now-retracted Science paper about the potential dangers of microplastics to fish.

Eklov will receive 800,000 ($94,784 USD) each year in 2018-2020 and 900,000 ($106,632 USD) in 2021, totalling 3,300,000 ($355,440 USD). The granting agency is the Swedish Research Council, controlled by Sweden’s Ministry of Education and Research.

Eklöv‘s retracted paper — which he co-authored with Oona Lönnstedt — got significant media coverage when it first appeared in June 2016, as it suggested fish larvae prefer to eat microplastic over their own natural prey. But soon after it was published, a group of researchers raised several allegations, including that the paper contained missing data and used a problematic methodology Continue reading Caught Our Notice: Author of controversial retracted paper earns Swedish gov’t grant

Most editors of top medical journals receive industry payments: report

Victoria Wong

When examining the roles of conflicts of interest in academic publishing, most research focuses on transparency around the payments authors receive. But what about journal editors? According to a new Peer J preprint, two-thirds of editors at prominent journals received some type of industry payment over the last few years – which, at many journals, editors are never required to disclose. (The findings echo those reported by another recent paper in The BMJ, published six days later.) We spoke with Victoria Wong at The Queens Medical Center in Hawaii, first author of the Peer J preprint.

Retraction Watch: In studies of academic integrity, most people concentrate on the authors who submit to journals, and on the articles published by journals, as a way to assess the integrity of science publications.  What drew your attention to the individual editors and their possible influence on the process?

Continue reading Most editors of top medical journals receive industry payments: report

17 Johns Hopkins researchers resign in protest from ed board at Nature journal

More than a dozen members of the editorial board at Scientific Reports have resigned after the journal decided not to retract a 2016 paper that a researcher claims plagiarized his work.

As of this morning, 19 people — mostly researchers based at Johns Hopkins — had stepped down from the board, according to Hopkins researcher Steven Salzberg. Salzberg organized the response after learning of the issue from colleague Michael Beer, who has accused the 2016 paper of plagiarism.

Monday morning, Richard White, the editor of the journal (published by Springer Nature), sent an email to Salzberg and the researchers who had threatened to resign if the paper wasn’t retracted, saying:

Continue reading 17 Johns Hopkins researchers resign in protest from ed board at Nature journal

Researchers ask to retract cancer paper five days after it’s flagged by journal

Researchers from the University of Kansas asked to retract their paper only days after the journal issued an expression of concern related to some of the images.

The retraction notice marks the close of an episode that started in June, but it doesn’t provide much closure: Figures in the paper apparently do not match primary data, but there’s no hint as to how that happened.

In a statement sent to JCS — just five days after the expression of concern came out — last author Kristi Neufeld, a cancer biologist at KU, wrote: Continue reading Researchers ask to retract cancer paper five days after it’s flagged by journal

Caught Our Notice: 4th retraction for prominent physicist (with new funding) cites falsification

Via Wikimedia

Title: Improved Cellular Specificity of Plasmonic Nanobubbles versus Nanoparticles in Heterogeneous Cell Systems

What Caught Our Attention: Nanotechnology researcher Dmitri Lapotko, whose work with lasers continues to catch media attention, has earned his fourth retraction.  As with the other three, the latest notice mentions an investigation at Rice University, but provides no specific information other than “data falsification” for images, and no indication as to the offending researcher(s). (In the past, Rice hasn’t even confirmed to us the presence of an investigation.) Only Laptoko and Ekaterina Lukianova-Hleb are common authors to all retractions. Despite these recent setbacks, Lapotko has not fared too badly in research funding.  Continue reading Caught Our Notice: 4th retraction for prominent physicist (with new funding) cites falsification